FAKTOR OPTIONSSCHEIN - SMITH & NEPHEW | Real-time BOERSE MUENCHEN 10:26:55 2024-05-23 am EDT | ||
| 15.64 EUR | +5.11% |
|
| Current month | -6.00% | ||
| 1 month | -4.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 15.64 | +5.11% |
| 24-05-22 | 14.88 | +0.47% |
| 24-05-21 | 14.81 | +2.70% |
| 24-05-20 | 14.42 | -0.89% |
| 24-05-17 | 14.55 | -0.07% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 10:26 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Goldman Sachs |
| WKN | GG33J6 |
| ISIN | DE000GG33J65 |
| Date issued | 2024-02-12 |
| Strike | 1,535 p |
| Maturity | Unlimited |
| Parity | 0.41 : 1 |
| Emission price | 13.63 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.96 € |
|---|---|
| Lowest since issue | 12.24 € |
| Spread | 0.15 € |
| Spread % | 0.95% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.92
USD
Average target price
16.31
USD
Spread / Average Target
+26.28%
- Stock Market
- Certificates
- Certificat
